US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
The US Food and Drug Administration on Friday rejected Bharat Biotech’s proposal for emergency use authorisation of its coronavirus, Covaxin. The development comes at a time when many countries do not recognise Covaxin. For more, watch the full video.